Benjamin P. Linas MD
Professor, Infectious Diseases
Professor, Epidemiology
771 Albany St | (617) 414-5238belinas@bu.edu
benjamin.linas@bmc.org

Sections
Infectious Diseases
Biography
Dr. Linas is a national leader in hepatitis-C virus (HCV) infection and HCV/HIV co-infection comparative- and cost-effectiveness research using computational biology, clinical epidemiology and clinical economics methods. Dr. Linas has an excellent track record of productivity, ample funding from the NIH and CDC, and a growing core of successful trainees. Dr. Linas directs the HIV/HCV core of the Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV, funded by the National Institute on Drug Abuse (NIDA) in collaboration with Cornell, U Penn and Miami.
Websites
Boston-Providence Center for AIDS Research
NIDA Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV
Education
Medicine, MD, New York University School of Medicine
Clinical Evaluation/Research, MPH, Harvard School of Public Health
Economics, BA, Yale University
Publications
Leech AA, Garbett S, Yu HA, McNeer E, Bharadwaj R, Linas BP, Graves J, Young J, Su L, Martin PR, Ward MJ, Ellingham MN, Kozhimannil KB, Samuels LR, Shi J, Patrick SW. Cost-Effectiveness of Treatment for Opioid Use Disorder in Pregnancy and Its Impact on Birth Outcomes. JAMA Pediatr. 2025 Sep 08. PMID: 40920396.
Published on 8/19/2025Mustanski B, Benbow N, Macapagal K, Li D, Madkins K, Saber R, Linas B, Smith JD, Brown CH, Munroe S, Reddy S, Schackman BR, Swann G, Janulis P, Zamantakis A, Zapata JP. Comparing Implementation and Effectiveness Outcomes for Two Implementation Strategies of the Keep It Up! Digital HIV Prevention Program: A Type 3 Hybrid Effectiveness-Implementation Trial. AIDS Behav. 2025 Aug 19. PMID: 40826259.
Published on 8/12/2025Haukoos J, Rothman RE, Galbraith JW, Hopkins E, Hsieh YH, Lyle C, Gravitz S, Kamis KF, White DAE, Lyons MS, Gardner EM, Al-Tayyib AA, Sabel AL, Linas BP, Morgan JR, Wyles DL, Rowan SE. Hepatitis C Screening in Emergency Departments: The DETECT Hep C Randomized Clinical Trial. JAMA. 2025 Aug 12; 334(6):497-507. PMID: 40632510.
Published on 7/15/2025Zhu L, Furukawa NW, Thompson WW, Reitsma MB, Randall LM, Asher AK, Valverde E, Linas BP, Salomon JA. Potential impact of frequent testing for hepatitis C virus among people who inject drugs toward hepatitis C elimination in the United States. Clin Infect Dis. 2025 Jul 15. PMID: 40662534.
Published on 7/9/2025Rudel RK, Kaufmann ND, Burrowes SAB, Harding C, Solomon C, Linas BP, Drainoni ML, Barnett KG. Harnessing storytelling with medical students and community members to build curiosity and trust: A mixed methods evaluation of a pilot intervention. PEC Innov. 2025 Dec; 7:100420. PMID: 40697280.
Published on 7/3/2025Zhu L, Furukawa NW, Thompson WW, Reitsma MB, Randall LM, Van Handel M, Asher AK, Valverde E, Linas BP, Salomon JA. Health and Economic Impact of Periodic Hepatitis C Virus Testing Among People Who Inject Drugs. JAMA Health Forum. 2025 Jul 03; 6(7):e251870. PMID: 40608305.
Published on 6/2/2025Zwick H, O'Dea R, Barocas JA, Flam-Ross JM, Chatterjee A, Walley AY, Harris RA, Schackman BR, White LF, Chrysanthopoulou SA, Assoumou SA, Murphy SM, Morgan JR, Baptiste D, Carroll M, Linas BP. Health and Economic Outcomes of Addressing Encampments of Individuals Using Opioids. JAMA Netw Open. 2025 Jun 02; 8(6):e2517095. PMID: 40577017.
Published on 5/1/2025Curtis MR, Munroe S, Biondi BE, Ciaranello AL, Linas BP, Epstein RL. Disparities in Linkage to Care Among Children With Hepatitis C Virus in the United States. Pediatrics. 2025 May 01; 155(5). PMID: 40246302.
Published on 4/21/2025Linas BP, Weitz M, Pramanick T, Sulkowski M, Smeaton LM, Cardoso SW, Solomon S. Health economic outcomes of a minimal monitoring approach to providing HCV therapy. Hepatol Commun. 2025 May 01; 9(5). PMID: 40257357.
Published on 4/17/2025Barocas JA, Aldridge A, Adkins KF, Barbosa C, Battaglia TA, Bush J, Castry M, Corry G, Clarke T, El-Bassel N, Figueroa W, Freedman DA, Freisthler B, Gibbons B, Gibson EB, Glasgow L, Harlow K, Huerta TR, Hunt T, Johnson R, Larimore E, Linas BP, Luckey JM, Montoya I, Murphy SM, Oga E, Onuoha E, Orme S, Ryan D, Schackman BR, Seiber EE, Singer M, Speer D, Starbird L, Tin Y, Villani J, Walsh SL, Watson C, Zarkin GA, McCollister K. An economic analysis of community costs incurred to implement the communities that HEAL intervention to reduce opioid overdose deaths in four states. Drug Alcohol Depend. 2025 Jul 01; 272:112671. PMID: 40311556.
Media Mentions
Published on 7/25/2025
The ‘Big Beautiful Bill’ May Lead to More Fatal Overdoses
Published on 7/16/2025
Addiction funding withheld by Trump administration
Published on 7/26/2024
How to combat a new surge of COVID-19 cases
Published on 11/6/2023
How to protect yourself from the 'tripledemic' of COVID-19, flu and RSV this winter
Published on 5/11/2023
Ask The Docs: the COVID emergency ends, and a new RSV vaccine in the works
Published on 2/14/2023
Boston Doctors Explain What to Know as Norovirus Cases Spread in Mass.
Published on 2/14/2023
The X-waiver for buprenorphine prescribing is gone. It’s time to spread the word
Published on 2/7/2023
US to Stop Offering Free COVID Vaccines This Fall: What it Means For Mass.
Published on 1/24/2023
Boston doctors answer listener questions about COVID
Published on 1/8/2023
Health Check: Diversity in Clinical Trials
View full list of 164 media mentions.